{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:33:12Z","timestamp":1789702392574,"version":"4.0.1"},"reference-count":36,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,17]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Juvenile myelomonocytic leukemia (JMML) is an aggressive pediatric myelodysplastic syndrome or myeloproliferative disorder for which hematopoietic stem cell transplantation remains the only curative option; however, outcomes are particularly poor in patients harboring PTPN11 (encodes SHP2 phosphatase) mutations. Using a Shp2E76K\/+ JMML mouse model, we identified a pathogenic interleukin-17A (IL-17A)\/PTGS2\/NLRP3 signaling axis that drives bone marrow inflammation, suppresses antitumor immunity, and promotes leukemic progression. Shp2E76K\/+ mice exhibited profound immune dysregulation, characterized by expansion of regulatory T cells, increased T-cell exhaustion, and impaired cytotoxic function with reduced CD4+ and CD8+ T-cell frequencies. Mechanistically, mutant macrophages upregulated IL-17A, triggering NLRP3 inflammasome activation, PTGS2 induction, caspase-1 cleavage, and IL-1\u03b2 maturation, thereby amplifying inflammatory signaling within the marrow niche. Therapeutically, IL-17A neutralization suppressed inflammasome activity, whereas the combined inhibition of NLRP3 and PTGS2 restored cytotoxic T-cell function, reduced systemic and marrow inflammation, reversed myeloproliferation, and significantly prolonged survival in Shp2E76K\/+ mice. Importantly, ex vivo treatment of primary samples from patients with JMML with dual NLRP3\/PTGS2 inhibition combined with mitogen-activated protein kinase kinase (MEK) blockade significantly reduced leukemic progenitor colony formation, supporting translational relevance. In patient-derived xenograft models of PTPN11-mutant JMML, dual NLRP3\/PTGS2 inhibition combined with MEK blockade most effectively reduced leukemic burden, decreased human CD45+ engraftment, and depleted leukemic CD34+CD38+ progenitors and granulocyte-macrophage progenitors while restoring megakaryocyte-erythroid progenitor populations, resulting in significantly improved overall survival. Together, these findings establish IL-17A\/PTGS2\/NLRP3 signaling as a central driver of immune suppression and myeloid expansion in PTPN11-mutant JMML and highlight combinatorial anti-inflammatory targeting as a promising therapeutic strategy for this high-risk disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025032588","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:10:37Z","timestamp":1780485037000},"page":"1605-1620","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic targeting of IL-17A\u2013driven PTGS2\/NLRP3 inflammasome activation in juvenile myelomonocytic leukemia"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5770-7187","authenticated-orcid":false,"given":"Santhosh Kumar","family":"Pasupuleti","sequence":"first","affiliation":[{"name":"1Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2206-5720","authenticated-orcid":false,"given":"Baskar","family":"Ramdas","sequence":"additional","affiliation":[{"name":"1Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5983-0066","authenticated-orcid":false,"given":"Kanaka Sai","family":"Ram Padam","sequence":"additional","affiliation":[{"name":"1Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6039-461X","authenticated-orcid":false,"given":"Rahul","family":"Kanumuri","sequence":"additional","affiliation":[{"name":"1Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9516-6278","authenticated-orcid":false,"given":"Lakshmi Reddy","family":"Palam","sequence":"additional","affiliation":[{"name":"1Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7545-4619","authenticated-orcid":false,"given":"Ramesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"1Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2913-9319","authenticated-orcid":false,"given":"Tzu-Chieh","family":"Ho","sequence":"additional","affiliation":[{"name":"1Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0107-5920","authenticated-orcid":false,"given":"Alex G.","family":"Lee","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Benioff Children\u2019s Hospital and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade D.","family":"Clapp","sequence":"additional","affiliation":[{"name":"1Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4256-8652","authenticated-orcid":false,"given":"Cheng-Kui","family":"Qu","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Aflac Cancer & Blood Disorders Center, Winship Cancer Institute, Children\u2019s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-4623","authenticated-orcid":false,"given":"Elliot","family":"Stieglitz","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Benioff Children\u2019s Hospital and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yang","sequence":"additional","affiliation":[{"name":"1Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN"},{"name":"4Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Kapur","sequence":"additional","affiliation":[{"name":"1Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN"},{"name":"4Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2026091711214377600_bib1","first-page":"1","article-title":"Juvenile myelomonocytic leukemia-A comprehensive review and recent advances in management","volume":"11","author":"Gupta","year":"2021","journal-title":"Am J Blood Res"},{"issue":"1","key":"2026091711214377600_bib2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2004-05-1944","article-title":"Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS\/EBMT trial","volume":"105","author":"Locatelli","year":"2005","journal-title":"Blood"},{"issue":"5","key":"2026091711214377600_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pbc.21038","article-title":"Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria","volume":"49","author":"Bergstraesser","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"7628","key":"2026091711214377600_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nature20131","article-title":"Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment","volume":"539","author":"Dong","year":"2016","journal-title":"Nature"},{"key":"2026091711214377600_bib5","doi-asserted-by":"crossref","first-page":"e73040","DOI":"10.7554\/eLife.73040","article-title":"Inflammatory response in hematopoietic stem and progenitor cells triggered by activating SHP2 mutations evokes blood defects","volume":"11","author":"Solman","year":"2022","journal-title":"Elife"},{"issue":"4","key":"2026091711214377600_bib6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/jcp.24815","article-title":"Cyclooxygenase-2 regulates NLRP3 inflammasome-derived IL-1\u03b2 production","volume":"230","author":"Hua","year":"2015","journal-title":"J Cell Physiol"},{"issue":"2-3","key":"2026091711214377600_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10555-018-9752-y","article-title":"The roles of the COX2\/PGE2\/EP axis in therapeutic resistance","volume":"37","author":"Tong","year":"2018","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"2026091711214377600_bib8","first-page":"734","article-title":"Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer","volume":"62","author":"Keith","year":"2002","journal-title":"Cancer Res"},{"key":"2026091711214377600_bib9","doi-asserted-by":"crossref","first-page":"610492","DOI":"10.3389\/fimmu.2020.610492","article-title":"Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks","volume":"11","author":"Lin","year":"2020","journal-title":"Front Immunol"},{"issue":"9","key":"2026091711214377600_bib10","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1158\/0008-5472.CAN-06-4174","article-title":"Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells","volume":"67","author":"Sinha","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"2026091711214377600_bib11","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41467-020-15497-1","article-title":"Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"2026091711214377600_bib12","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ymthe.2023.01.030","article-title":"Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia","volume":"31","author":"Pasupuleti","year":"2023","journal-title":"Mol Ther"},{"issue":"11","key":"2026091711214377600_bib13","doi-asserted-by":"crossref","first-page":"e163968","DOI":"10.1172\/JCI163968","article-title":"Obesity-induced inflammation exacerbates clonal hematopoiesis","volume":"133","author":"Pasupuleti","year":"2023","journal-title":"J Clin Invest"},{"issue":"14","key":"2026091711214377600_bib14","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1182\/bloodadvances.2020002123","article-title":"Role of lncRNA Morrbid in PTPN11(Shp2)E76K-driven juvenile myelomonocytic leukemia","volume":"4","author":"Cai","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"2026091711214377600_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MOH.0b013e328353c6bf","article-title":"Shp2 function in hematopoietic stem cell biology and leukemogenesis","volume":"19","author":"Nabinger","year":"2012","journal-title":"Curr Opin Hematol"},{"issue":"10","key":"2026091711214377600_bib16","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.20110450","article-title":"Non-lineage\/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells","volume":"208","author":"Xu","year":"2011","journal-title":"J Exp Med"},{"issue":"3","key":"2026091711214377600_bib17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.immuni.2016.08.009","article-title":"The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"issue":"2","key":"2026091711214377600_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8+ T cell exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"issue":"5","key":"2026091711214377600_bib19","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","article-title":"Distinct metabolic requirements of exhausted and functional virus-specific CD8 T cells in the same host","volume":"16","author":"Schurich","year":"2016","journal-title":"Cell Rep"},{"issue":"1","key":"2026091711214377600_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12885-020-06755-y","article-title":"PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma","volume":"20","author":"Furuse","year":"2020","journal-title":"BMC Cancer"},{"issue":"6","key":"2026091711214377600_bib21","doi-asserted-by":"crossref","first-page":"e20221472","DOI":"10.1084\/jem.20221472","article-title":"Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages","volume":"220","author":"Gonzalez","year":"2023","journal-title":"J Exp Med"},{"issue":"5","key":"2026091711214377600_bib22","first-page":"4360","article-title":"Cyclooxygenase-2 expressed hepatocellular carcinoma induces cytotoxic T lymphocytes exhaustion through M2 macrophage polarization","volume":"13","author":"Xun","year":"2021","journal-title":"Am J Transl Res"},{"issue":"1","key":"2026091711214377600_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1084\/jem.20131142","article-title":"CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets","volume":"211","author":"Smigiel","year":"2014","journal-title":"J Exp Med"},{"issue":"4","key":"2026091711214377600_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nri.2016.26","article-title":"T cell receptor signalling in the control of regulatory T cell differentiation and function","volume":"16","author":"Li","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2026091711214377600_bib25","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.4049\/jimmunol.0900191","article-title":"CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta","volume":"183","author":"Bollyky","year":"2009","journal-title":"J Immunol"},{"issue":"9","key":"2026091711214377600_bib26","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.4049\/jimmunol.174.9.5444","article-title":"A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection","volume":"174","author":"Suffia","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"2026091711214377600_bib27","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1038\/s41467-025-59040-6","article-title":"Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemia","volume":"16","author":"Werner","year":"2025","journal-title":"Nat Commun"},{"issue":"4","key":"2026091711214377600_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/FPC.0b013e32834f94cb","article-title":"Celecoxib pathways: pharmacokinetics and pharmacodynamics","volume":"22","author":"Gong","year":"2012","journal-title":"Pharmacogenet Genomics"},{"issue":"11","key":"2026091711214377600_bib29","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/sj.bjc.6604057","article-title":"COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia","volume":"97","author":"Farooqui","year":"2007","journal-title":"Br J Cancer"},{"issue":"2","key":"2026091711214377600_bib30","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1002\/mco2.147","article-title":"Role of chemokine systems in cancer and inflammatory diseases","volume":"3","author":"Li","year":"2022","journal-title":"MedComm"},{"key":"2026091711214377600_bib31","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.2147\/DDDT.S113683","article-title":"Spotlight on brodalumab in the treatment of moderate-to-severe plaque psoriasis: design, development, and potential place in therapy","volume":"11","author":"Roman","year":"2017","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"2026091711214377600_bib32","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.18632\/oncotarget.13819","article-title":"Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"2026091711214377600_bib33","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/biomedicines12071538","article-title":"Experimental insights on the use of secukinumab and magnolol in acute respiratory diseases in mice","volume":"12","author":"Vicovan","year":"2024","journal-title":"Biomedicines"},{"issue":"3","key":"2026091711214377600_bib34","doi-asserted-by":"crossref","first-page":"106062","DOI":"10.1016\/j.isci.2023.106062","article-title":"Tivantinib alleviates inflammatory diseases by directly targeting NLRP3","volume":"26","author":"Huang","year":"2023","journal-title":"iScience"},{"issue":"4","key":"2026091711214377600_bib35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","article-title":"NLRP3 inflammasome in neuroinflammation and central nervous system diseases","volume":"22","author":"Xu","year":"2025","journal-title":"Cell Mol Immunol"},{"issue":"suppl 1","key":"2026091711214377600_bib36","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1182\/blood-2023-190975","article-title":"Interleukin-17A directly signals to bone marrow-derived hematopoietic stem and progenitor cells to promote their expansion and differentiation in vitro [abstract]","volume":"142","author":"Losada","year":"2023","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/12\/1605\/2588689\/blood_bld-2025-032588-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/12\/1605\/2588689\/blood_bld-2025-032588-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:21:51Z","timestamp":1789658511000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/12\/1605\/568831\/Therapeutic-targeting-of-IL-17A-driven-PTGS2-NLRP3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9,17]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025032588","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,17]]},"published":{"date-parts":[[2026,9,17]]}}}